Usefulness of the skeletal muscle index in postoperative ileus of colorectal cancer patients : a case control study

doi:10.21203/rs.3.rs-1880406/v1

Background:

Postoperative complications of colorectal cancer mainly include infections (surgical site infection, remote infection, etc.), post-operative ileus (POI), and anastomosis leakage. POI reportedly prolongs the hospital stay and increases medical costs. Therefore, predicting POI is very important. There have been some reports on the relationships between sarcopenia and postoperative complications in colorectal cancer patients, but none have been limited to POI. We therefore conducted a retrospective clinical study with a logistic regression analysis to confirm the risk factors for ileus after colorectal cancer surgery.

Methods:

We retrospectively analyzed 213 patients who underwent radical surgery for colorectal cancer from November 2017 to July 2021. The skeletal muscle mass (SMM, kg) was estimated using a whole-body bioelectrical impedance analysis (BIA), and the skeletal muscle index (SMI) was calculated as the SMM / height². We divided all patients into 2 groups based on a low SMI (male <8.958 kg/m², female <8.443 kg/m²) or normal SMI. Preoperative and intraoperative factors as well as, postoperative outcomes were then compared between the two groups.

Results:

The median (range) age of the 213 included patients was 72.0 (33-91) years old. Complications were noted in 100 patients (46.9 %), including 21 (9.9 %) with POI. There were 68 (31.9 %) low SMI patients. POI occurred significantly more frequently in low SMI patients (19.1 %) than in normal SMI patients (5.5 %) (p = 0.005). In the multivariate analysis, bleeding (p=0.005) and a low SMI (p = 0.044) were significantly associated with POI. In addition, a propensity score matching analysis was performed to further reduce the selection bias. As a result, a low SMI was the only independent POI predictor among the 74 matched cases.

Conclusion:

A preoperative low SMI in colorectal cancer patients was considered a risk factor for POI.

Colorectal cancer

Postoperative ileus

skeletal muscle index

Colorectal cancer (CRC) has the third-highest incidence and second-highest mortality rate among cancers, with over 1.93 million cases and 916,000 deaths a year [1]. Surgery is the only curative option. However, postoperative complications occur in a substantial number of cases [2, 3].

The definition of POI includes symptoms such as nausea, vomiting, and abdominal bloating as well as dilation of the small intestine without obvious obstruction as confirmed on imaging. Post-operative ileus (POI) increases post-operative morbidity and prolongs the hospital stay while increasing the medical costs [4–7]. Postoperative complications, including POI, after surgery for CRC are reportedly associated with delays in adjuvant chemotherapy, and patients who receive delayed adjuvant chemotherapy have higher recurrence rates and a worse overall survival than those who receive chemotherapy within eight weeks of surgical treatment [8]. Among the postoperative complications of CRC, the incidence of POI is reported to be 10%-30% after abdominal surgery and 15%-30% after colon [7, 9] and rectal surgery [10–12]. Therefore, predicting POI is very important in CRC surgery.

Furthermore, preoperative sarcopenia has been attracting attention in recent years as a predictor of postoperative complications. Sarcopenia was initially described in 1989 as a condition in which muscle mass decreases with age [13]. Sarcopenia is a condition with many causes and varying outcomes. While sarcopenia is mainly observed in older people, it can also develop in younger adults, as is likewise the case for dementia and osteoporosis. Sarcopenia is divided into primary sarcopenia in a narrow sense and secondary sarcopenia in a broad sense, depending on its origin. Primary sarcopenia is a decrease in muscle mass with aging, while secondary sarcopenia is a decrease in muscle mass associated with decreased activity, malnutrition, and diseases, such as organ failure and malignant tumors [14, 15].

Among CRC patients, the number of patients with primary sarcopenia due to aging of patients and secondary sarcopenia due to malnutrition or cancer-bearing status is increasing. Therefore, it is very important to understand the preoperative condition of the patient. There have been some reports on the relationships between sarcopenia and postoperative complications in CRC patients [16–18], but there have been no studies limited to POI thus far. We therefore investigated the relationship between sarcopenia and POI in CRC patients.

This study was conducted in accordance with the ethical principles based on the Declaration of Helsinki and was approved by the Institutional Review Board of Osaka Metropolitan University Graduate School of Medicine (reference number 4182).

Patients and specimens

We retrospectively analyzed 213 consecutive patients with CRC who underwent radical surgery at Osaka City University Hospital from November 2017 to July 2021.

We excluded patients with double cancer and those who received preoperative chemo-radiotherapy as well as patients who underwent combined hepatic resection. The following clinical and surgical data were collected from electronic medical records: age, gender, body mass index (BMI), patient history, and blood test results.

Patients’ clinicopathological characteristics are summarized in Table 1. The histological diagnosis was based on the World Health Organization criteria[19]. Pathologic staging was performed according to the 8th edition of the Union for International Cancer Control TNM classification of malignant tumors [20].

Table 1

Clinicopathologic characteristics of 213 colorectal cancer patients
Clinicopathologic features		n = 213
Gender	male	126 (59.2%)
	female	87 (40.8%)
Age(years)*	Mean (SD)	72 (11.3)
BMI*	Mean (SD)	23.2 (4.1)
Comorbidities
	Cardiac disease	37 (17.3%)
	Lung disease	23 (10.8%)
	Diabetes mellitus	46 (21.6%)
Location of tumor	C	17
	A	42
	T	20
	D	8
	S	46
	R	80
pT stage	Tis-T2	93 (43.7%)
	T3-T4	120 (56.3%)
pN stage	Negative	153 (61.8%)
	Positive	60 (28.2%)
pStage	0	10
	I	73
	II	63
	III	49
	IV	18
Surgery	Laparoscopic surgery	187 (87.8%)
	Open surgery	26 (12.2%)
Operative time(min)*	Mean (SD)	265.9 (111.9)
Intraoperative bleeding(ml)*	Mean (SD)	117.5 (332.1)
Postoperative complication
	All	100 (46.9%)
	Surgical site infection	52 (24.4%)
	Anastomotic leakage	17 (8.0%)
	POI	21 (9.9%)
	CDC grade
	I	21 (9.9%)
	II	53 (24.9)
	IIIa	20(9.4%)
	IIIb	6(2.8%)
	IVa	1(0.5%)
Continuous parameters are presented as mean (SD), and categorical parameters are presented as n (%), C cecum cancer, A ascending colon cancer, T transverse colon cancer, D descending colon cancer, S sigmoid colon cancer, R rectum cancer, Tis* carcinoma in situ, POI postoperative ileus, CDC Clavien-Dindo classification, SD standard deviation,

Postoperative complications

The results of postoperative complications are also shown in Table 1. Postoperative complications were defined as in-hospital morbidity or mortality occurring within 30 days of surgery and classified according to the Clavien-Dindo Classification (CDC) [21].

Surgical site infections (SSIs), anastomotic leakage, and postoperative ileus (POI) were included among postoperative complications.

POI

POI was defined in cases with symptoms such as nausea, vomiting, and abdominal bloating as well as dilation of the small intestine without obvious obstruction confirmed on imaging.

Skeletal muscle index (SMI)

All patients had their skeletal muscle mass (SMM) measured by a bioelectrical impedance analysis (BIA) method using an InBody®S10 (InBody Japan, Tokyo, Japan) two days before their surgery. Using the formula for calculating the SMI (kg/m²) [SMM / (patient height)²] we generated SMIs for each patient. The low SMI group (L group) was defined as those with values lower than the sex-specific cut-off values (8.958 and 8.443 kg/m² for males and females, respectively) by the point on the receiver operating characteristic (ROC) curve predicting POI (Fig. 1A, 1B). All patients were classified into the L group or normal SMI group (N group) based on these cut-off values.

Propensity score matching (PSM)

A PSM analysis was used to adjust for differences in clinicopathological characteristics between the L and N groups. The variables were sex, age (continuous), comorbidities (cardiac, pulmonary, diabetes mellitus), BMI (continuous), Onodera’s prognostic nutritional index (PNI = 10 × Alb (g/dl) + 0.005 × lymphocytes [/µl], continuous), all of which are associated with the SMI. Each variable was multiplied by a coefficient that was calculated using a logistic regression analysis, and the sum of these values was taken as the propensity score for individual patients. The L and N groups were matched 1:1 based on their propensity scores using nearest-neighbor matching without replacement (caliper size: 0.1). If no suitable match within the 0.1 caliper size remained in the control group, the exposed patient was excluded from the matched data set.

Statistical analyses

The data of continuous variables were described as the median (interquartile range [IQR]). A univariate analysis was performed by the chi-squared test or Fisher's exact for categorical variables. To identify predictors of POI, multivariate analyses including variables with p < 0.05 in the univariate analyses were performed using the logistic regression model. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. All statistical analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), which is a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria). More precisely, it is a modified version of R commander designed to add statistical functions frequently used in biostatistics [22].

Patient characteristics

A total of 213 (126 male and 87 female) patients were identified in this study. The median age was 72.0 (33–91) (Table 1). According to the ROC curve analysis, all patients were classified into two groups: L group (n = 68, male SMI < 8.958 kg/m², female SMI < 8.443 kg/m²) and the N group (n = 145) based on the SMI cut-off values (Fig. 1A, 1B). Thirty-seven patients had comorbid cardiac disease, 23 had lung disease (defined as a % vital capacity of < 60% or a % forced expiratory volume in 1.0 second of < 50%), and 46 had diabetes mellitus.

Postoperative complications were observed in 100 cases (46.9%). SSI was observed in 52 cases, anastomosis leakage was observed in 17 cases, and POI was observed in 21 cases (9.9%). The POI onset occurred on average 3.2 days after surgery, and 1 of 15 cases required ileus tube insertion, while 4 cases required nasogastric(NG) tube insertion. It took an average of 5.6 days for the condition to improve. Patients with POI had a significantly longer postoperative hospital stay than the non-onset patients (Fig. 2).

Correlation between the SMI and clinicopathological characteristic factors

Regarding preoperative factors, the L group was had a significantly older age, higher rate of female participants, lower preoperative BMI, higher rate of lung diseases and non-diabetes mellitus, and lower PNI than the N group, according to a univariate analysis (Table 2). No significant differences were found between the groups in any of the cancer progression or intraoperative factors. Regarding postoperative complication factors, the frequency of POI was significantly higher in the L group than in the N group (p = 0.005).

Table 2

Association between preoperative decrease in skeletal muscle mass and clinical pathological background
Back Ground	Low SMI (n = 68)	Normal SMI(n = 145)	P-value
Sex
female	45 (66.2%)	42 (29.0%)	< 0.001
Age(years)*
mean (SD)	73.1 (11.2)	68.4 (11.0)	0.004
BMI*
mean (SD)	20.6 (3.3)	24.4 (3.9)	< 0.001
PNI*
mean (SD)	45.3 (6.3)	47.0 (6.5)	0.076
GPS
2 over	4 (5.9%)	13(9.0%)	0.591
Alb(g/dL)*
mean (SD)	3.8 (0.5)	3.9 (0.5)	0.266
Cardiac disease
Positive	9(13.2%)	28(19.3%)	0.334
Lung Disease
Positive	12 (17.6%)	11 (7.6%)	0.034
Diabetes mellitus
Positive	7 (10.3%)	39(26.9%)	0.007
Tumor location
Left sided tumor	38 (55.9%)	96(66.2%)	0.171
Tumor Size
≧ 3.0cm	40 (61.5%)	83 (58.9%)	0.761
pT stage
T3 over	40 (58.8%)	80 (55.2%)	0.658
pN stage
Positive	23 (33.8%)	37 (25.5%)	0.253
P
Positive	4 (5.9%)	4(2.8)	0.270
H
Positive	4 (5.9%)	8 (5.5%)	1.0
Surgical procedure
Laparoscopy	57(83.8%)	130(89.7%)	0.263
Operative time
≦ 240min	34 (50.0%)	76 (52.4%)	0.770
Bleeding
≧ 101ml	12 (17.6%)	28 (19.3%)	0.852
CDC
Grade 3 over	5 (7.4%)	21 (14.5%)	0.179
Complications
SSI	12 (17.6%)	40 (27.6%)	0.127
Anastomotic leakage	3 (4.4%)	14 (9.7%)	0.279
POI	13 (19.1%)	8 (5.5%)	0.005
Continuous parameters are presented as mean (SD), and categorical parameters are presented as n (%), SMI* skeletal muscle index, BMI body mass index, PNI prognostic nutritional index, GPS glasgow prognostic score, Alb albumin, Lung disease was defined as a condition with % vital capacity < 60% or a % force expiratory volume in 1.0 second < 50%, TNM tumor node metastasis, P peritoneal dissemination, H hepatic metastasis, CDC clavien–dindo classification, SSI surgical site infection, POI post operative ileus, P < 0.05

Univariate and multivariate analyses for POI

Table 3 shows the relationship of the clinicopathological characteristics with POI. A low BMI (p = 0.015), bleeding (p = 0.005), and low SMI (p = 0.003) were significantly associated with POI in the univariate analysis. The multivariate analysis including variables with p < 0.1 in univariate analyses, revealing that bleeding (p = 0.005, OR = 3.900, 95% CI 1.51-10.00) and a low SMI (p = 0.003, OR = 4.05, 95% CI 1.59–10.30) were independent predictors of POI.

Table 3

Association between POI and clinicopathological characteristics
	Univariate analysis			Multivariate analysis
Variable	Hazard	95%CI	P-value	Hazard	95%CI	P-value
Sex
Female	0.70	0.27–1.81	0.463
Age
	1.000	0.96–1.04	0.981
BMI
	0.833	0.719–0.965	0.015	0.891	0.761–1.04	0.149
PNI
	0.959	0.896–1.03	0.235
GPS
2 over	0.555	0.069–4.37	0.572
Alb
	0.795	0.343–1.84	0.594
Cardiac disease
Positive	1.13	0.358–3.59	0.831
Lung Disease
Positive	1.43	0.388-5.30	0.589
Diabetes mellitus
Positive	1.15	0.398–3.33	0.795
Tumor location
Left sided tumor	0.617	0.249–1.53	0.296
Tumor Size
≧3.0cm	0.889	0.357–2.21	0.800
pT stage
T3 over	1.04	0.417–2.58	0.938
pN stage
Positive	0.778	0.272–2.23	0.641
P
Positive	1.320	0.155–11.30	0.799
H
Positive	0.823	0.1010–6.710	0.855
Surgical procedure
Laparoscopy	2.54	0.846–7.660	0.096	0.747	0.186–3.01	0.682
Operative time
≦ 240 min	1.2	0.48–2.95	0.698
Bleeding
≧ 101ml	3.900	1.51-10.00	0.005	5.480	1.65–18.2	0.005
SMI
Low SMI	4.05	1.59–10.30	0.003	3.110	1.030–9.41	0.044
CDC
Grade 3 over	0.737	0.161–3.36	0.693
Complications
SSI	0.706	0.226–2.22	0.548
Anastomotic leakage	0.550	0.069–4.37	0.572
CI confidence interval, P < 0.05

PSM

To reduce the possibility of selection bias, PSM was performed. After PSM, 37 matched pairs were created. The patient characteristics before and after PSM are shown in Table 4. After PSM, the two groups did not show any significant differences in clinicopathological characteristics.

Table 4

Clinicopathological characteristics before and after propensity score matching
		All patients			Matched patients
Variable		Low SMI (n = 68)	Normal (n = 145)	P-value	Low SMI (n = 37)	Normal (n = 37)	P-value
Sex	Male	23 (33.8%)	103 (71.0%)		19 (51.4%)	17 (45.9%)
	Female	45 (66.2%)	42 (29.0%)	< 0.001	18 (48.6%)	20 (54.1%)	0.816
Age(years) *
mean (SD)		73.1 (11.2)	68.4 (11.0)	0.004	72.5 (11.4)	71.9 (10.4)	0.816
BMI*
mean (SD)		20.6 (3.3)	24.4 (3.8)	< 0.001	21.7 (3.6)	21.8 (2.4)	0.861
PNI*
mean (SD)		45.3 (6.3)	47.0 (6.5)	0.076	46.7 (6.7)	46.8 (5.9)	0.985
GPS	0,1	64 (94.1%)	132 (91.0%)		36 (97.3%)	33 (89.2%)
	2	4 (5.9%)	13 (9.0%)	0.591	1 (2.7%)	4 (10.8%)	0.358
Alb(g/dL)*
mean (SD)		3.79 (0.5)	3.88 (0.5)	0.268	3.88 (0.4)	3.87 (0.5)	0.895
Cardiac disease	positive	9 (13.2%)	28 (19.3%)		2 (5.4%)	5 (13.5%)
Cardiac disease	negative	59 (86.8%)	117 (80.7%)	0.334	35 (94.6%)	32 (86.5%)	0.430
Lung disease	positive	12 (17.6%)	11 (7.6%)		7 (18.9%)	5 (13.5%)
Lung disease	negative	56 (82.4%)	134 (92.4%)	0.034	30 (81.1%)	32 (86.5%)	0.375
Diabetes Mellitus	positive	7 (10.3%)	39 (26.9%)		6 (16.2%)	6 (16.2%)
Diabetes Mellitus	negative	61 (89.7%)	106 (73.1%)	0.007	31 (83.8%)	31 (83.8%)	1.000
Tumor side	Right	30 (44.1%)	49 (33.8%)	0.696	14 (37.8%)	13 (35.1%)
	Left	38 (55.9%)	96 (66.2%)	0.171	23 (62.2%)	24 (64.9%)	1.000
Tumor Size(cm)	≧ 3.0	25 (38.5%)	58 (41.1%)		19 (54.3%)	20 (55.6%)
	< 3.0	40 (61.5%)	83 (58.9%)	0.761	16 (45.7%)	16 (44.4%)	1.000
pT stage	≧ 3	40 (58.8%)	65 (44.8%)		18 (48.6%)	19 (51.4%)
	0–2	28 (41.2%)	80 (55.2%)	0.658	19 (51.4%)	18 (48.6%)	1.000
pN stage	positive	23 (33.8%)	37 (25.5%)		9 (24.3%)	9 (24.3%)
	negative	45 (66.2%)	108 (74.5%)	0.253	28 (75.7%)	28 (75.7%)	1.000
P	positive	4 (5.9%)	4 (2.8%)		2 (5.4%)	2 (5.4%)
	negative	64 (94.1%)	141 (97.2%)	0.270	35 (94.6%)	35 (94.6%)	1.000
H	positive	4 (5.9%)	8 (5.5%)		1 (2.7%)	3 (8.1%)
	negative	64 (94.1%)	137 (94.5%)	1.000	36 (97.3%)	34 (91.9%)	0.615
Surgical Procedure	Open	11 (16.2%)	15 (10.3%)		4 (10.8%)	4 (10.8%)
Surgical Procedure	Lap	57 (83.8%)	130 (89.7%)	0.263	33 (89.2%)	33 (89.2%)	1.000
Operative Time(min)	≧ 240	34 (50.0%)	69 (47.6%)		18 (48.6%)	18 (48.6%)
Operative Time(min)	༜240	34 (50.0%)	76 (52.4%)	0.770	19 (51.4%)	19 (51.4%)	1.000
Bleeding(ml)	≧ 101	12 (17.6%)	28 (19.3%)		4 (10.8%)	6 (16.2%)
Bleeding(ml)	༜101	56 (82.4%)	117 (80.7%)	0.852	33 (89.2%)	31 (83.8%)	0.736
Continuous parameters are presented as mean (SD)*, and categorical parameters are presented as n (%), P < 0.05

Univariate and multivariate analyses for POI in 74 matched patients

Table 5 shows the results of the univariate analysis for POI in 74 matched patients. A low BMI (p = 0.0471) and low SMI (p = 0.035) were significantly associated with POI in a univariate analysis. The multivariate analysis including variables with p < 0.2 in univariate analyses, revealing that a low SMI (p = 0.040, OR = 9.900, 95% CI 1.110–88.50) was the only independent predictor of POI in 74 matched patients.

Table 5

Univariate and multivariate analysis for POI in matched patients with colorectal cancer.
			Univariate analysis	Multivariate analysis
Variable	POI	Non-POI	P-value	Hazard	95%CI	P-value
Sex
Female	3 (33.3%)	35 (53.8%)	0.258
Age*
mean (SD)	66.8 (17.2)	73.0 (9.6)	0.114	0.780	0.560–1.070	0.123
BMI*
mean (SD)	19.8 (1.9)	22.0 (3.1)	0.047	0.956	0.895–1.020	0.182
PNI*
mean (SD)	47.2 (5.31)	46.7 (6.4)	0.816
GPS
> 2	0 (0.0%)	5 (7.7%)	1.000
Alb(g/dL)*
mean (SD)	3.9 (0.3)	3.9 (0.5)	0.690
Cardiac disease
Positive	0 (0.0%)	7 (10.8%)	NA
Lung Disease
Positive	0 (0.0%)	12 (18.5%)	NA
Diabetes mellitus
Positive	1 (11.1%)	11 (16.9%)	0.660
Surgical procedure
Laparoscopy	8 (88.9%)	58 (89.2%)	0.975
Tumor location
Left sided tumor	4 (44.4%)	43 (66.2%)	0.215
Tumor Size
≧ 3.0cm	6 (66.7%)	33 (53.2%)	0.453
pT stage
T3 over	5 (55.6%)	32 (49.2%)	0.732
pN stage
Positive	2 (22.2%)	16 (24.6%)	0.875
P
Positive	1 (11.1%)	3 (4.6%)	0.434
H
Positive	0 (0.0%)	4 (6.2%)	NA
Operative time
≦ 240min	5 (55.6%)	31 (47.7%)	0.659
Bleeding
≧ 101ml	2 (22.2%)	8 (12.3%)	0.422
SMI
Low SMI	8 (88.9%)	29 (44.6%)	0.035	9.900	1.110–88.50	0.040
SSI
Positive	2 (22.2%)	14 (21.5%)	0.963
Anastomotic leakage
Positive	0 (0.0%)	6 (9.2%)	NA
Continuous parameters are presented as mean (SD)*, and categorical parameters are presented as n (%), P < 0.05

In the present study, we examined POI in 213 cases of CRC surgery. The incidence of POI was 21 (9.9%). This frequency was almost the same as previously reported. Cases with POI showed a significant extension of hospital stay: 21.7 days compared to 14.7 days for non-POI cases. Previous reports have also reported that POI leads to extended hospital stays. Furthermore, in this study, a low SMI was an independent predictor of POI. To our knowledge, this is the first report on the relationship between POI and a low SMI. We report that SMI is a useful predictive marker for the occurrence of POI.

To date, several risk factors of POI have been reported, including hypoalbuminemia, lung disorders, male sex, a large amount of bleeding, and a long operation time [7, 9–12, 23]. The implementation of standardized accelerated postoperative care pathways, namely oral antibiotic bowel preparation, early NG tube removal, early ambulation, early oral feeding, patient education, opioid-sparing epidural analgesia, perioperative fluid management, and minimally invasive surgical techniques has been reported to reduce the risk of POI [7, 24]. However, despite the widespread implementation of these measures, the incidence of POI for CRC is still reported to be 10%-30% after abdominal surgery [7, 9] and 15%-30% after colon and rectal surgery [10–12]. Therefore, predicting POI is very important in CRC surgery.

In the present study, univariate and multivariate analyses demonstrated that bleeding was associated with POI. However, the relationship between the POI and the previously reported non-bleeding data (hypoalbuminemia, lung disorders, male sex, and a long operation time) has not been elucidated in this study. Regarding the influence of bleeding on POI, it has been reported that an increase in hemoglobin drop due to the addition of colloidal fluid for intraoperative bleeding causes electrolyte imbalance, inducing intestinal edema [23]. Our results also demonstrated an association between bleeding and POI.

PSM was performed to further reduce the selection bias. As a result, a low SMI was found to be the only independent POI predictor in our examination of 74 matched cases.

The importance of sarcopenia in perioperative management has been shown in recent years, and there are a number of reports on the relationship between sarcopenia and postoperative complications. Lieffers et al. reported that 39% of 234 CRC surgery patients had sarcopenia, and the sarcopenia group showed a longer postoperative stay and more frequent infectious complications than the non-sarcopenia group [16]. Furthermore, the association between sarcopenia and postoperative complications has also been reported in patients with other cancer types such as esophageal cancer, gastric cancer and pancreatic cancer [25–28].

However, to our knowledge, no report on the relationship between SMI and POI has yet been published. There have been recent reports of decreased intestinal peristalsis in patients with sarcopenia. According to the report by Vaes et al., the generation of contractile forces by the gastrointestinal musculature is further regulated by the smooth muscle contractile activity, and the enteric nervous system, consisting of the myenteric plexuses and the interstitial cells of Cajal. In cancer patients with sarcopenia, a decreased expression of a contractile smooth muscle marker called smoothelin and the accumulation of collagen around the intestinal plexus are both known to occur, thus resulting in an impairment of both the intestinal smooth muscle contractile function and its regulation [29]. An in vivo study showed that the loss of smoothelin resulted in irregular slow wave patterns, impaired intestinal contraction, and hampered intestinal transit [30]. It was also reported that structural alterations in the myenteric plexus in tumor-bearing rats resulted in decreased upper gastrointestinal transit [31].

These previous findings therefore suggest that patients with sarcopenia already have factors that predispose them to intestinal motility disorders, so they may be prone to developing POI induced by surgical intervention.

Our present findings suggested that sarcopenia in cancer patients was associated with the development of POI. It is important to predict the occurrence of POI, and by promoting intestinal peristalsis and inserting an NG tube for postoperative nausea, aspiration due to ileus can be prevented. Preoperative sarcopenia patients are at high risk of developing POI, so it is important to take appropriate measures, such as promoting intestinal peristalsis early after surgery and inserting a NG tube early when symptoms appear, to prevent POI.

However, several limitations associated with the present study warrant mention. First, this study was retrospective and conducted in a single institution with a relatively small sample size. Second, the definition of a low SMI was determined by a BIA, and we did not investigate muscle power or function. Currently, there are no clear criteria for sarcopenia in Japanese patients, so it is also necessary to consider whether or not the SMI is appropriate for defining sarcopenia. Finally, although we determined cut-off values for the SMI based on the results of ROC curve analyses as an objective statistical method, an optimal standardized method for determining optimal cut-off values should be established. Further prospective studies with larger numbers of patients are needed to validate the utility of the preoperative SMI for predicting POI.

A low SMI was an independent predictor of POI. The measurement of the preoperative SMI by the BIA method is very simple, and is considered a useful approach to predicting the onset of POI in patients after CRC surgery.

Ethics approval and consent to participate

The following study was carried out under the approval of the ethics committee of our institution (Osaka Metropolitan University Graduate School of Medicine, reference number 4182) and with the informed consent of the participants, in order to evaluate the results obtained.

Consent for publication

Not applicable.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Competing interests

We declare that we have no conflict of interest.

Funding

This study has no funding sources.

Author contributions

Maho Sasaki designed the study, performed the statistical analysis and draft the manuscript; Tatsunari Fukuoka designed the study, performed the statistical analysis and draft the manuscript; Masatsune Shibutani collected the clinical data and revised the manuscript critically; Atsushi Sugimoto collected the clinical data and revised the manuscript critically; Kiyoshi Maeda designed the study and critically reviewed the manuscript; Masaichi Ohira designed the study and critically reviewed the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We have no acknowledgments.

Ferlay J EM, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020 (https://gco.iarc.fr/today, accessed February 2021).
Pattamatta M, Smeets BJJ, Evers S, Rutten HJT, Luyer MDP, Hiligsmann M: Health-related quality of life and cost-effectiveness analysis of gum chewing in patients undergoing colorectal surgery: results of a randomized controlled trial. Acta Chir Belg 2018, 118(5):299–306.
van Rooijen S, Carli F, Dalton S, Thomas G, Bojesen R, Le Guen M, Barizien N, Awasthi R, Minnella E, Beijer S et al: Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation. BMC Cancer 2019, 19(1):98.
Asgeirsson T, El-Badawi KI, Mahmood A, Barletta J, Luchtefeld M, Senagore AJ: Postoperative ileus: it costs more than you expect. J Am Coll Surg 2010, 210(2):228–231.
Holte K, Kehlet H: Postoperative ileus: a preventable event. Br J Surg 2000, 87(11):1480–1493.
Rybakov EG, Shelygin YA, Khomyakov EA, Zarodniuk IV: Risk factors for postoperative ileus after colorectal cancer surgery. Colorectal Dis 2017.
Moghadamyeghaneh Z, Hwang GS, Hanna MH, Phelan M, Carmichael JC, Mills S, Pigazzi A, Stamos MJ: Risk factors for prolonged ileus following colon surgery. Surg Endosc 2016, 30(2):603–609.
Tevis SE, Kohlnhofer BM, Stringfield S, Foley EF, Harms BA, Heise CP, Kennedy GD: Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival. Dis Colon Rectum 2013, 56(12):1339–1348.
Vather R, Trivedi S, Bissett I: Defining postoperative ileus: results of a systematic review and global survey. J Gastrointest Surg 2013, 17(5):962–972.
Chapuis PH, Bokey L, Keshava A, Rickard MJ, Stewart P, Young CJ, Dent OF: Risk factors for prolonged ileus after resection of colorectal cancer: an observational study of 2400 consecutive patients. Ann Surg 2013, 257(5):909–915.
Millan M, Biondo S, Fraccalvieri D, Frago R, Golda T, Kreisler E: Risk factors for prolonged postoperative ileus after colorectal cancer surgery. World J Surg 2012, 36(1):179–185.
Hain E, Maggiori L, Mongin C, Prost AlDJ, Panis Y: Risk factors for prolonged postoperative ileus after laparoscopic sphincter-saving total mesorectal excision for rectal cancer: an analysis of 428 consecutive patients. Surg Endosc 2018, 32(1):337–344.
Rosenberg IH: Summary comments: Epidemiological and methodological problem in determining nutritional status of older persons. Am J Clin Nutr 1989, 50:1231–1233.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM et al: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010, 39(4):412–423.
Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P et al: Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr 2010, 29(2):154–159.
Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE: Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012, 107(6):931–936.
Reisinger KW, van Vugt JL, Tegels JJ, Snijders C, Hulsewé KW, Hoofwijk AG, Stoot JH, Von Meyenfeldt MF, Beets GL, Derikx JP et al: Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 2015, 261(2):345–352.
Nakanishi R, Oki E, Sasaki S, Hirose K, Jogo T, Edahiro K, Korehisa S, Taniguchi D, Kudo K, Kurashige J et al: Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today 2018, 48(2):151–157.
Jeremy R. Jass LHS: Histological typing of intestinal tumours. In WHO International Histological Classifcation of Tumours. Springer 1989.
James D. Brierley: Colon and rectum. In: TNM Classification of Malignant Tumours (UICC). 8th ed. Oxford. Wiley-Blackwell 2017.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004, 240(2):205–213.
Kanda Y: Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013, 48(3):452–458.
Vather R, Bissett IP: Risk factors for the development of prolonged post-operative ileus following elective colorectal surgery. Int J Colorectal Dis 2013, 28(10):1385–1391.
Delaney CP, Marcello PW, Sonoda T, Wise P, Bauer J, Techner L: Gastrointestinal recovery after laparoscopic colectomy: results of a prospective, observational, multicenter study. Surg Endosc 2010, 24(3):653–661.
Mayanagi S, Ishikawa A, Matsui K, Matsuda S, Irino T, Nakamura R, Fukuda K, Wada N, Kawakubo H, Hijikata N et al: Association of preoperative sarcopenia with postoperative dysphagia in patients with thoracic esophageal cancer. Dis Esophagus 2021, 34(9).
Ida S, Watanabe M, Yoshida N, Baba Y, Umezaki N, Harada K, Karashima R, Imamura Y, Iwagami S, Baba H: Sarcopenia is a Predictor of Postoperative Respiratory Complications in Patients with Esophageal Cancer. Ann Surg Oncol 2015, 22(13):4432–4437.
Chen XY, Li B, Ma BW, Zhang XZ, Chen WZ, Lu LS, Shen X, Zhuang CL, Yu Z: Sarcopenia is an effective prognostic indicator of postoperative outcomes in laparoscopic-assisted gastrectomy. Eur J Surg Oncol 2019, 45(6):1092–1098.
Pessia B, Giuliani A, Romano L, Bruno F, Carlei F, Vicentini V, Schietroma M: The role of sarcopenia in the pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci 2021, 25(10):3670–3678.
Vaes RDW, Welbers TTJ, Dijk DPJ, Rennspiess D, zur Hausen A, Damink SWMO, Rensen SS: Intestinal smooth muscle aberrations in pancreatic cancer patients with sarcopenia. JCSM Rapid Communications 2021, 4(2):187–196.
Niessen P, Rensen S, van Deursen J, De Man J, De Laet A, Vanderwinden JM, Wedel T, Baker D, Doevendans P, Hofker M et al: Smoothelin-a is essential for functional intestinal smooth muscle contractility in mice. Gastroenterology 2005, 129(5):1592–1601.
Marega P, Liberti EA, Freitas JJS, Kietzer KS: Walker-256 tumor alters morphology of intestinal myenteric plexus in rats. Neurogastroenterol Motil 2018.

No competing interests reported.

Usefulness of the skeletal muscle index in postoperative ileus of colorectal cancer patients : a case control study

Status:

Version 1

Abstract

Figures

Introduction

Materials And Methods

Patients and specimens

Postoperative complications

POI

Skeletal muscle index (SMI)

Propensity score matching (PSM)

Statistical analyses

Results

Patient characteristics

Correlation between the SMI and clinicopathological characteristic factors

Univariate and multivariate analyses for POI

PSM

Univariate and multivariate analyses for POI in 74 matched patients

Discussion

Conclusion

Declarations

References

Competing Interests

Status:

Version 1